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Alpha Synuclein only Forms Fibrils In Vitro when Larger
than its Critical Size of 70 Monomers
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Francesco Simone Ruggeri,[a, d] Eric Hidari,[a, e] and David Klenerman*[a, e]
The aggregation of α-synuclein into small soluble aggregates
and then fibrils is important in the development and spreading
of aggregates through the brain in Parkinson’s disease. Fibrillar
aggregates can grow by monomer addition and then break into
fragments that could spread into neighboring cells. The rate
constants for fibril elongation and fragmentation have been
measured but it is not known how large an aggregate needs to
be before fibril formation is thermodynamically favorable. This
critical size is an important parameter controlling at what stage
in an aggregation reaction fibrils can form and replicate. We
determined this value to be approximately 70 monomers using
super-resolution and atomic force microscopy imaging of
individual α-synuclein aggregates formed in solution over long
time periods. This represents the minimum size for a stable α-
synuclein fibril and we hypothesis the formation of aggregates
of this size in a cell represents a tipping point at which rapid
replication occurs.
Introduction
A body of data has shown how intrinsically disordered proteins
such as beta amyloid, tau and α-synuclein aggregate in the
test-tube and the rate constants for the key molecular steps
have recently been determined.[1–6] α-Synuclein monomers have
been shown to rapidly form small globular proteinase-K-
sensitive aggregates by monomer addition which then undergo
a slow structural conversion to fibrillar proteinase-K-resistant
aggregates, that then can rapidly grow into fibrils by further
addition of monomers.[1,6] Experiments over longer times have
shown that these fibrils can fragment into smaller aggregates
and hence replicate in the test-tube5. It is speculated that a
similar process takes place in neurons in the brain and leads to
the spreading of α-synuclein from neuron to neuron in a
mechanism often referred to as prion-like spreading.[4]
The formation of fibrillar aggregates from a solution of
monomeric proteins generally involves three types of processes;
primary nucleation, which forms the initial aggregates directly
from monomer; elongation, which grows existing aggregates
by addition of monomers from solution; and multiplication,
which increases the number of aggregates, for example by
fragmentation or secondary nucleation on the surface of
existing aggregates.[7] A key parameter to describe an aggregat-
ing system is its rate of replication, k, whose inverse is
proportional to the time it takes to double the number of fibrils.
It can be shown that quite generally this replication rate is
determined by the product of the elongation and multiplication
rates.[8] Through measurements of the aggregation of purified
α-synuclein, the rate constants for elongation and fragmenta-
tion of fibrillar aggregates of α-synuclein have recently been
determined.[4] However, it is not known how large an aggregate
needs to be before conversion from a pre-fibrillar to intermedi-
ate and mature cross-β fibrillar forms is favorable. This quantity
is important since it defines the minimum size of a replication-
competent fibrillar aggregate. If this size is large then
fragmentation is more likely to produce an aggregate below
this size, slowing down the rate of replication. However, this
size has not been directly measured to date nor has the effect
of a large critical size been explored in detail in chemical
kinetics models of aggregation.
There is limited data from cellular experiments that suggest
possible values of this minimum size. Experiments using
sonicated fibrils of different sizes, separated using a sucrose
gradient, suggest that α-synuclein aggregates of about 75–
100 nm or less in length are not seed competent.[9] This result is
a combination of the probability of cell entry and probability of
seeding and hence not a direct measurement of critical size.
Super-resolution imaging experiment in live cells, where cellular
components may modify the thermodynamics of fibril forma-
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tion, found a critical diameter of about 320 nm by fitting a first
order phase transition for protein aggregate formation, pre-
sumed to be α-synuclein aggregates.[10] In contrast, data on
prion protein aggregates, which may also contain co-factors,
show that the minimal diameter of an infectious particle is 17–
27 nm.[11]
Super-resolution imaging technology has already proved a
useful tool in detecting and characterizing individual aggregate
species with high specificity.[12] In this work, we use super-
resolution fluorescence microscopy and atomic force micro-
scopy to directly measure the size distributions of α-synuclein
aggregates formed in vitro and determine the critical size at
which fibrillar aggregates are formed.
Results and Discussion
Homogeneous 500 nM and 1 μM recombinant α-synuclein
monomer solutions were allowed to fully aggregate under
shaking conditions at 37 °C. Aggregates were imaged with
Aptamer-DNA Point Accumulation for Imaging in Nanoscale
Topography (AD-PAINT) using a total internal reflection
fluorescence (TIRF) microscope, as has been previously
published.[12] These super-resolution images make it possible to
distinguish morphological differences between the highly linear
α-synuclein fibrils and the comparatively more abundant, small-
er, globular species which make up the vast majority of
aggregates formed near physiological concentrations of α-
synuclein (1 μM) (Figure 1a). We used the eccentricity of the
aggregates to distinguish fibrillar aggregates from globular
aggregates (Figure 1 b and c). Over time, longer fibrillar
aggregates with eccentricities greater than 0.95 form. The high
eccentricity aggregates had a median length of 74 nm, while
the aggregates with an eccentricity of less than 0.7 had a
median length of 25 nm. Aggregates with eccentricities be-
tween 0.7 and 0.95 that could not be clearly classified had an
intermediate median length of 54 nm. We noted that there was
a clear transition between the low and high eccentricity
aggregates at approximately 40 nm. Below this length the
aggregates were more likely to have low eccentricity and above
this length they were more likely to have high eccentricity.
To confirm this result we performed high-resolution and
phase controlled atomic force microscopy to acquire 3-D
morphology maps of α-synuclein aggregation and single
amyloid fibrillar species at the nanoscale. The aggregates were
formed under the same conditions, but at 45 μM α-synuclein
concentration, to generate more fibrillar aggregates for imaging
and single-molecule statistical analysis without the need to
dilute the sample, since dilution might alter the aggregate size
distribution.[11] In this case the sample is dried onto positive
functionalized mica to image the negatively charged aggre-
gates. The 3-D maps at higher spatial resolution obtained from
AFM allows us to distinguish intermediate protofilaments, with
a cross-sectional diameter of 0.3–4 nm, protofibrillar species
which are long, flexible and thin, 2–5 nm diameter, from fibrils
which are more mature and thicker, and have cross-sectional
diameter in the range of 6–10 nm.[13] The length distribution of
protofilaments, the first elongated species appearing in the
aggregation pathway, showed an average length of 280�
180 nm (Figure 2a–c). Because of their higher flexibility, proto-
filaments are more dynamic when imaged under solution using
super resolution and hence will tend to appear spherical and
less elongated. By contrast, mature fibrils appeared straight and
showed a mean length of 120�60 nm and a minimal length of
50�10 nm, in excellent agreement with the super-resolution
imaging data. Importantly these data, based on measurement
of 75 fibrils show a clear cut-off at short lengths and are
consistent with a transition from a long protofilament to a short
fibril of 50�10 nm in length since we do not observe fibrils
shorter than 40 nm (Figure 2d). This is entirely consistent with
the results of the super-resolution imaging experiments.
To determine the importance of a minimum size for fibril
formation we used a model which accounts for the observation
that protofibrillar α-synuclein must undergo a structural
reconfiguration prior to growing into stable fibrillar aggregates.
In the standard models of protein aggregation the minimum
stable fibril size, also referred to as the nucleus size, is generally
assumed to be negligibly small.[6,13,14] Therefore, any loss of fibril
mass due to fragmentation into aggregates smaller than this
minimum size is not an important effect in these descriptions.
Here, we have explicitly considered the effect of a large
minimum size and derived updated expressions for both the
replication rate and the steady state average fibril size. For a
Figure 1. Super-resolution imaging of α-synuclein aggregates with Ap-
tamer DNA -PAINT. a) Selected individual aggregates demonstrating varying
size and morphology of α-synuclein aggregates as they progress to mature
fibrils (scale bar=1 μm). b) Length distributions of low, intermediate, and
high eccentricity aggregates (defined as eccentricity <0.7, 0.7–0.95, >0.95,
respectively) formed from homogenous monomer concentrations of 500 nM
and 1 μM α-synuclein between 7 and 22 days of incubation in Tris buffer at
pH 7.5 with shaking at 37 °C (n=214,075). There was no difference in the
length distribution between the 500 nM and 1 μM data so they were
merged. c) Example AD-PAINT images of aggregates with low and high
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, and the steady state average size, in numbers




, where k+ is the elongation rate
constant, kf is the fragmentation rate constant and m0 is the
monomer concentration at the beginning of the reaction. When
we take into account that fragmentation can generate fibrils
smaller than the critical size, which will then dissociate, we find
that the replication rate is given approximately by
�k ¼ k   kfnc and �m ¼ mþ nc, (1)
where nc is the minimum stable fibril size (the bar denoting
quantities when the minimum size is taken into account). A
detailed derivation can be found in the methods. This
approximation is accurate for critical sizes up to the steady state
length m, but breaks down for larger values. It can easily be
shown that the effect of critical size becomes important for
both the replication rate and the steady state size when nc
approaches in magnitude the steady state length μ. In other
words, the effect of a minimum stable fibril size can be ignored
if it is much shorter than the average size of the aggregates.
The fact that the minimum size observed in our experiment is
close to the average size indicates that indeed the minimum
size, in addition to the rate constants of fragmentation and
growth, is a key factor in determining the speed at which α-
synuclein fibrils can replicate. We illustrate the importance of
accounting for this factor in Figure 3 where taking account of
the critical size reduces the doubling time by a factor of two for
0.1 μM α-synuclein. The magnitude of this effect increases the
lower the α-synuclein concentration.
It is not possible to obtain the critical aggregate size from a
chemical kinetic analysis of an aggregation reaction measured
using a dye like Thioflavin T, since high-resolution length
distributions are required. Therefore, the critical size has not
been determined for any aggregation reaction to date. Our
results show that the critical length for formation of α-synuclein
mature fibrils is about 40 nm. Aggregates with a smaller length
and containing a smaller number of monomers appear to not
be stable in this fibrillar form and instead exist as longer,
thinner protofilaments and protofibrils and as smaller spherical
aggregates, which contain fewer monomers.
We can obtain a lower bound on the number of monomers
in the minimum size fibril of 40 nm length and diameter of
6 nm using the standard density of a folded protein of
Figure 2. High-resolution 3D AFM imaging of α-synuclein protofilaments
and fibrils formed in Tris buffer. Morphology maps showing a) a protofila-
ment and its cross-sectional diameter. b) Fibril and its cross-sectional
diameter. c) Fibrils of varying length. d) Single-molecule statistical analysis
and length distribution of synuclein protofilaments and fibrils.
Figure 3. Effect of minimum stable fibril size on aggregation kinetics and
size distribution. (a,b) The increase in aggregate mass over time, for a
minimum stable fibril size of 2 (a) and 70 (b). (c,d) The size distribution at
400 h and 500 h for the respective cases. The corresponding times are
marked by dashed lines in a and b. (e) Comparing the doubling time of
aggregate replication when the minimum fibril size is taken into account
and when it is neglected. While at 1 μM the doubling times are similar, at
lower concentrations neglecting the loss of fibrils due to fragmentation
below the minimum size results in doubling times that are significantly
higher than the actual ones. (f) Schematic of the mechanism of aggregation.
Initial fibrils are formed by primary nucleation, grow by elongation and
multiply by fragmentation. Fragmentation into pieces smaller than the
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1.35 kg · L  1. This gives an estimate of the critical size as 64
monomers. We can also estimate the number of monomers in a
protofilament, since we previously demonstrated that the
protofilaments in Figure 2a result from the direct assembly of
α-synuclein monomers into a linear chain.[13] If we assume that
there is one monomer per 4 nm of a single-strand protofilament
(diameter partially folded monomer),[14] we obtain an average
number of 70 monomers per protofilament and a range of
protofilament sizes between 10 and 130 monomers. Thus, a
significant subpopulation of protofilaments contains enough
monomers to form a stable fibril. Therefore, in agreement with
our previous kinetic analysis,[6] the conversion from protofila-
ment to fibril could be a unimolecular process. Previous work
established the rate of conversion to be on the order of 0.1 h  1,
under the assumption that all measured oligomeric species are
taking place in that conversion reaction.[6] However, our findings
suggest that, in fact, only a subset of the oligomeric population
is large enough to convert to stable fibrils, thus the concen-
tration of conversion-competent species was overestimated and
consequently the conversion rate underestimated. Based on our
previous measurements of the oligomer size distribution,[6] we
conclude that the conversion rate is at least 2 orders of
magnitude higher than previously estimated, giving rapid
conversion times of a few minutes or less.
To be an effective seed, a fibril would need to be able to
produce two new fibrils that are larger than the critical length,
so the seed effectiveness will depend on the balance of growth
and fragmentation rates as well as the size of the seed. Altered
rates in cells may explain why the observed minimal effective
seed sizes under those conditions are somewhat larger than the
minimal stable fibril size we observe here.[9] Previous work has
estimated the critical radius for aggregate formation by what is
believed to be α-synuclein to be about 160 nm, giving a
diameter of 320 nm, in cells, suggesting that a critical transition
occurs in living cells.[10] The value of 320 nm obtained in cells is
significantly larger than the value obtained in our study in
solution and may represent a different transition that occurs for
larger aggregates in the cellular environment. Fibrillar aggre-
gates may also be significantly destabilised in the cellular
environment, possibly due to post-translational modifications.
Additionally, the labels used in the cellular experiments may
destabilise the fibrillar aggregates. Finally, smaller aggregates
may also be more susceptible to cellular removal processes,
skewing the size distribution. Thus, experiments imaging the
aggregates in cells without labels would be needed to help
determine the origin of this difference.
The role of prion-like spreading in causing aggregation in
neighbouring neurons in neurodegenerative disease is a subject
of intense research and, in particular, it is not clear how
potential fibril seeds are formed. However, it is clear that cells
can spontaneously form aggregates under conditions of
increased protein expression or cell stress. Our result combined
with our recent study of seeding in cells[15] suggests that once
aggregates larger than the critical size are formed in the cytosol
they can convert to the fibrillar form and replicate by
elongation and fragmentation very rapidly. Hence, the cell must
continuously remove or secrete aggregates to prevent them
growing by monomer addition to 70-mers, since aggregates of
this size can convert within minutes into fibrils. In our recent
study of SH5Y cells we observed no accumulation of aggregates
in the cell but significant secretion of small aggregates of about
35 nm in size under basal conditions which increased when the
cell were seeded.[15] Hence, preventing aggregates from reach-
ing their critical size appears to be a key cellular protective
mechanism. We speculate that formation of aggregates larger
than 70-mers, 40 nm in size, may be the tipping point that
overwhelms the protein homeostasis of the cellular machinery.
Conversely, preventing formation of fibrillar aggregates of this
size or finding ways to increase the critical size may be a
general strategy to reduce or prevent aggregate induced cell
death.
Conclusion
In summary, we have shown that an aggregate of α-synuclein
will only form fibrils when it contains more than 70 monomers
and this value determines the minimum size of an α-synuclein
“prion”. Aggregates with fewer than 70 monomers have a
different structure and properties from mature fibrils. Our work
defines a simple framework to determine this critical size for
other proteins associated with neurodegenerative disease, such
as beta amyloid and tau, and to determine the effect of
mutations or different conditions on this length. Our modelling
shows that this critical size is an important parameter that
governs the rate of aggregate replication, together with the
elongation and fragmentation rate constant, and this large
critical size for α-synuclein may contribute to its slow spreading
observed in vivo.
Experimental Section
Please see the Supporting Information for detailed experimental
procedures.
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